Circulating immune checkpoints predict heart failure outcomes

Circulating immune checkpoints predict heart failure outcomes

Abstract Aims There are limited data examining the role of immune checkpoint (IC) ligands in the pathophysiology of heart failure (HF). Therefore, we explore this in three HF animal models and in three different human cohorts (healthy, stable, and worsening HF). Methods and results Transcriptomic an...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak:	Elles M. Screever, Laura I.E. Yousif, Javid J. Moslehi, Joe‐Elie Salem, Adriaan A. Voors, Herman H.W. Silljé, Rudolf A. deBoer, Wouter C. Meijers
Formatua:	Artikulua
Hizkuntza:	English
Argitaratua:	Wiley 2023-08-01
Saila:	ESC Heart Failure
Gaiak:	Immune checkpoints PD‐L1 PD‐L2 Galectin‐9 Heart failure
Sarrera elektronikoa:	https://doi.org/10.1002/ehf2.14304

Antzeko izenburuak

Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study
nork: Douglas B. Johnson, et al.
Argitaratua: (2019-05-01)

Checkpoint Inhibition in Myeloma: Opportunities and Challenges
nork: Federica Costa, et al.
Argitaratua: (2018-09-01)

The role of immune checkpoints in cardiovascular disease
nork: Laura I. Yousif, et al.
Argitaratua: (2022-10-01)

Enhancing cancer care with improved checkpoint inhibitors
nork: Vickram A S, et al.
Argitaratua: (2024-10-01)

Checkmate with checkpoint inhibitors: New paradigm in immunotherapy
nork: Ruby Dhar, et al.
Argitaratua: (2023-04-01)

Characterization of PD-1/PD-L1 Immune Checkpoint Expression in Osteosarcoma
nork: Kazuhiko Hashimoto, et al.
Argitaratua: (2020-07-01)

Immune Checkpoint in Glioblastoma: Promising and Challenging
nork: Jing Huang, et al.
Argitaratua: (2017-05-01)

Phytochemicals in Cancer Immune Checkpoint Inhibitor Therapy
nork: Juwon Lee, et al.
Argitaratua: (2021-07-01)

Overview of the Cardiotoxicity Induced by PD-1/PD-L1 Immune Checkpoint Inhibitor in Critical Care
nork: Ruiting Li, et al.
Argitaratua: (2021-06-01)

On Demand Biosensors for Early Diagnosis of Cancer and Immune Checkpoints Blockade Therapy Monitoring from Liquid Biopsy
nork: Sai Mummareddy, et al.
Argitaratua: (2021-12-01)

PD-1/PD-L1 immune checkpoint inhibitors in glioblastoma: clinical studies, challenges and potential
nork: Tianrui Yang, et al.
Argitaratua: (2021-02-01)

PD-L1 expression on malignant cells is no prerequisite for checkpoint therapy
nork: Jan Willem Kleinovink, et al.
Argitaratua: (2017-04-01)

Epigenetic modifications of the immune-checkpoint genes CTLA4 and PDCD1 in non-small cell lung cancer results in increased expression
nork: Sebastian Marwitz, et al.
Argitaratua: (2017-05-01)

Immune Checkpoint Inhibitors in Cancer Therapy
nork: Yavar Shiravand, et al.
Argitaratua: (2022-04-01)

Research Progress on Cardiotoxicity of PD-1/PD-L1 Immune Checkpoint Inhibitors
nork: YU Lin, et al.
Argitaratua: (2021-08-01)

The Role of Immune Checkpoint Inhibitors in Cancer Therapy
nork: Ahmed M. Basudan
Argitaratua: (2022-12-01)

The role of immune checkpoint inhibitors in prostate cancer
nork: Gabriel Surdacki, et al.
Argitaratua: (2019-03-01)

Editorial: The Roles of Checkpoint Inhibitors in Inflammatory Diseases
nork: Andreas von Knethen, et al.
Argitaratua: (2021-10-01)

Activity and Safety of Immune Checkpoint Inhibitors in Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis
nork: Alberto Bongiovanni, et al.
Argitaratua: (2021-05-01)

Predictive Biomarkers of Immune Checkpoint Inhibitors-Related Toxicities
nork: Ya Xu, et al.
Argitaratua: (2020-10-01)

Structural Characterization of a Macrocyclic Peptide Modulator of the PD-1/PD-L1 Immune Checkpoint Axis
nork: Edyta Zyla, et al.
Argitaratua: (2021-08-01)

The Neonatal Innate Immune Response to Sepsis: Checkpoint Proteins as Novel Mediators of This Response and as Possible Therapeutic/Diagnostic Levers
nork: Emily Hensler, et al.
Argitaratua: (2022-07-01)

Key questions about the checkpoint blockade-are microRNAs an answer?
nork: Mihnea Dragomir, et al.
Argitaratua: (2018-06-01)

Vascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in Cancer
nork: Maria Georganaki, et al.
Argitaratua: (2018-12-01)

Enhancement of anti-tumor efficacy of immune checkpoint blockade by alpha-TEA
nork: William L. Redmond, et al.
Argitaratua: (2023-02-01)

The epigenetic immunomodulator, HBI-8000, enhances the response and reverses resistance to checkpoint inhibitors
nork: Reid P. Bissonnette, et al.
Argitaratua: (2021-08-01)

Advances in immune checkpoint inhibitors for hepatocellular carcinoma
nork: Ji Won Han, et al.
Argitaratua: (2021-09-01)

Immune Checkpoint Inhibitors: Ctla-4 and Pd-1/Pd-l1 in Immunotherapy
nork: Kübra KAHVECİ, et al.
Argitaratua: (2019-12-01)

Radiation, Immune Checkpoint Blockade and the Abscopal Effect: A Critical Review on Timing, Dose and Fractionation
nork: Zachary S. Buchwald, et al.
Argitaratua: (2018-12-01)

Safety and efficacy of PD-1/PD-L1 immune checkpoint inhibitors in patients with pre-treated advanced stage malignant mesothelioma: a systematic review and meta-analysis
nork: Amjad Zafar, et al.
Argitaratua: (2024-11-01)

The impact of antibiotic use on clinical features and survival outcomes of cancer patients treated with immune checkpoint inhibitors
nork: Jiaxin Zhou, et al.
Argitaratua: (2022-07-01)

Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
nork: Adel Naimi, et al.
Argitaratua: (2022-04-01)

Editorial: Biomarkers of Immune-Checkpoint-Inhibitor Immunotherapies in Hepatocellular Carcinomas
nork: Zhanjun Guo, et al.
Argitaratua: (2022-03-01)

Profiling targetable immune checkpoints in osteosarcoma
nork: Troy A McEachron, et al.
Argitaratua: (2018-12-01)

The Use of Phytochemicals to Improve the Efficacy of Immune Checkpoint Inhibitors: Opportunities and Challenges
nork: Deniz Can Guven, et al.
Argitaratua: (2022-10-01)

Commentary: Chronic PD-1 Checkpoint Blockade Does Not Affect Cognition or Promote Tau Clearance in a Tauopathy Mouse Model
nork: Kuti Baruch, et al.
Argitaratua: (2020-05-01)

NSCLC: from tumorigenesis, immune checkpoint misuse to current and future targeted therapy
nork: Leona Raskova Kafkova, et al.
Argitaratua: (2024-02-01)

Efficacy and safety of immune checkpoint inhibitors in non-small cell lung cancer
nork: Shuai Wang, et al.
Argitaratua: (2018-08-01)

PD/1-PD-Ls Checkpoint: Insight on the Potential Role of NK Cells
nork: Silvia Pesce, et al.
Argitaratua: (2019-06-01)

In Search of Better Peptide-(Derived from PD-L2)-Based Immune Checkpoint Inhibitors
nork: Boris Klebansky, et al.
Argitaratua: (2024-05-01)